A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 121 participants.

Also called NCT04437862

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 121 participants (enrolled count) (from the registry)
Sponsor
MIVI Neuroscience, Inc. (from the registry)
Registry
  • NCT NCT04437862
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04437862. Allocation not applicable; no masking; primary purpose treatment. Start 2020-10-27 (actual); primary completion 2023-04-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Evaluate the Q Revascularization System for Neurointervention in Acute Ischemic Stroke
Acronym
EvaQ
Condition
Acute Stroke
Condition
Cerebral Ischemia
Intervention (Device)
Q Revascularization System
Lead sponsor
MIVI Neuroscience, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04437862
Content hash
9fcbdd17a920d08cbfba871f0e0249b75b1af550fab14d864a66ea6bf2cf127a